The EMA’s human medicines advisory committee has recommended approval of Eli Lilly’s Baqsimi as ... priced at a similar level to the glucagon injection kits available on the market, with ...

The portfolio includes top brands like Prega News (pregnancy test kit), Manforce (condoms), Unwanted-72 (emergency contraceptive ... by Innovent and Eli Lilly. Sintilimab is expected to be ...

but the vast majority of people at risk of low blood glucose don’t carry an emergency kit. Supported by Xeris, the ADA wants to rectify low rates of glucagon prescriptions. The multi-year pact ...

Both companies are competing in GLP-1 (Glucagon-like Peptide-1) receptor agonists that help in promoting weight loss. BioSpace reported that Eli Lilly faces fierce competition from Novo Nordisk ...

Glucagon prescriptions for severe hypoglycemia in Medicaid initially decreased from 2012 to 2018 but increased between 2019 and 2023 following the introduction of newer products. Glucagon ...

Eli Lilly has invested heavily into obesity, dominating the landscape—alongside semaglutide maker Novo Nordisk—with its ...

The key to surviving these situations is simple preparation. A simple winter emergency kit can go a long way to helping you survive in the cold. What should be in your emergency kit for winter ...

But what exactly belongs in an emergency car kit? The answer varies depending on where you’re driving and what your needs are. I talked to experts in highway safety, vehicle preparedness and ...

The Vetoos Car Roadside Emergency Kit has all that and more. It's packed with everything you could need for most any pesky problem that forces you to pull off the road. Grab it on sale and rest a ...

The GLP-1 market is currently dominated by semaglutide (Ozempic and Wegovy) produced by Novo Nordisk A/S (NYSE: NVO) and tirzepatide (Mounjaro and Zepbound) produced by Eli Lilly and Co. (NYSE ...

Incretins such as glucagon-like peptide-1, or GLP-1, are used in diabetes and obesity drugs like Eli Lilly’s Mounjaro and Zepbound. The stock dropped 8.2% in morning trading, enough to make it ...